EDITION:
- EU
- NA
While many in the industry continue to extol the commercial opportunities of the cannabis industry in order to try and
While many in the industry continue to extol the commercial opportunities of the cannabis industry in order to try and
In the run-up to Cannabis Europa 2023, Prohibition Partners’ CEO Stephen Murphy caught up with Aras Azadian, co-founder and CEO of Avicanna. Stephen and Aras discuss Avicanna’s landmark partnership with Canadian pharmacy giant Shoppers Drug Mart, alongside reviewing differences between the Canadian and European industries, patient access and affordability and what to look forward to in the emerging European market.
Robin Emerson, CEO of the Jorja Emerson Centre, was introduced to the life changing impact medical cannabis can have after his daughter was diagnosed with a chromosome disorder which causes a severe form of epilepsy.
THE rollout of New York’s recreational cannabis market has been anything but smooth. Earlier this year, a federal court upheld an injunction blocking the state’s cannabis dispensary rollout in five regions.Â
With a general election looming, drugs policy in the UK could soon become a hot button issue for both politicians
Last July, five members of the European Parliament from different political groups and different EU Member States came together to
IN November 2022, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) released new detailed guidelines for medical cannabis companies operating
After 60-plus years of negativity and prohibition the tide has turned for hemp at the highest levels of global governance,
EARLIER this week, Czechia’s national anti-drug coordinator Jindřich Vobořil, described as the ‘locomotive’ driving rapid cannabis reform in the country,
We won’t spam you
© 2023 Prohibition Holdings Ltd. All Rights Reserved.